SCHEMBL623171

SCHEMBL623171

CN(C)C(CCc1c(C(=O)O)sc(N2CCOCC2)c1C#N)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 10/20 0.51
SLC6A2 P23975 2/20 0.38
SLC6A4 P31645 2/20 0.38
SLC6A3 Q01959 2/20 0.38
GRIA2 P42262 1/20 0.37
GRIA4 P48058 1/20 0.37
TACR2 P21452 1/20 0.36
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
OPRK1 P41145 1/20 0.35
UTS2R Q9UKP6 1/20 0.35
MTOR P42345 3/20 0.34
PIK3R1 P27986 3/20 0.34
P2RX7 Q99572 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL622461 0.90 PIK3CA (0.42) PIK3CASLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL622870 0.88 PIK3CA (0.54) PIK3CASLC6A2SLC6A4SLC6A3GRIA2
SCHEMBL623508 0.82 PIK3CA (0.52) PIK3CASLC6A2SLC6A4SLC6A3GRIA2
SCHEMBL623170 0.81 PIK3CA (0.49) PIK3CASLC6A2SLC6A4SLC6A3GRIA2
SCHEMBL623337 0.79 PIK3CA (0.58) PIK3CAGRIA2GRIA4CYP3A4CYP2D6
SCHEMBL10288545 0.79 PIK3CA (0.55) PIK3CASLC6A2SLC6A4SLC6A3GRIA2
SCHEMBL622984 0.79 PIK3CA (0.43) PIK3CASLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL622869 0.78 PIK3CA (0.52) PIK3CASLC6A2SLC6A4SLC6A3GRIA2
SCHEMBL3403807 0.77 PIK3CA (0.78) PIK3CAGRIA2GRIA4MTORPIK3R1
SCHEMBL622051 0.77 PIK3CA (0.55) PIK3CASLC6A2SLC6A4SLC6A3GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2603214-A1 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-06-19 EP disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed